18. Subsequent Events

Subsequent to March 31, 2025, through April 22, 2025, the Company sold 0.9 million ordinary shares under the Sales Agreement, with HC Wainwright as agent, at an average price of $1.12 per ordinary share for net proceeds of $957.

On April 28, 2025, the Company entered into a securities purchase agreement with an institutional investor pursuant to which it issued and sold an aggregate of (i) 3,040,000 ordinary shares, at a purchase price of $0.90 per ordinary share, and (ii) pre-funded warrants to purchase up to an aggregate of 2,515,556 ordinary shares at a purchase price of $0.89 per pre-funded warrant in the April 2025 Registered Direct Offering, for aggregate gross proceeds of approximately $5,000. Net proceeds after deducting the placement agent fees and offering expenses payable by us are expected to be approximately $4,200. Upon closing, the pre-funded warrants became exercisable immediately at an exercise price of $0.01 per ordinary share, subject to adjustment in certain circumstances, and

will expire when exercised in full, subject to certain conditions. As of May 13, 2025, pre-funded warrants issued in connection with the April 28, 2025 Offering had been exercised for 394,556 ordinary shares.